Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMP-4: Optimal Dosage of Atropine Plus Red Light for Myopia Control
ChiCTR2400084439Phase 3Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of atropine in myopia (4 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Changes in spherical equivalent refraction (SER) and Changes in axial length. Planned start May 2024; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2400084439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084439.